COVID-19 Trial Data
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19
Gilead Sciences
PR-M07-20-NI-015Jul 10, 2020
Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
Gilead Sciences
PR-M10-19-NI-017Oct 11, 2019
Leadership
Gilead Continues to Mix Things Up at the Executive Level
Nice Insight
PAO-M08-19-NI-014Aug 07, 2019
Collaboration
Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline
Kite
PR-M05-18-NI-066May 17, 2018